72138-73-9

Usage

Uses

Used in Medicinal Chemistry:
[1,3]dioxolo[4,5-b]pyridine serves as a valuable precursor in the synthesis of various pharmaceuticals, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemicals:
[1,3]dioxolo[4,5-b]pyridine is also utilized as a starting material in the creation of agrochemicals, playing a role in the development of products designed to enhance crop protection and yield.
Used in Drug Discovery:
The [1,3]dioxolo[4,5-b]pyridine structure has demonstrated potential for a range of pharmacological activities, making it a subject of ongoing research for its possible applications in treating various diseases and conditions.
Used in Synthetic Organic Chemistry:
Due to its unique chemical properties, [1,3]dioxolo[4,5-b]pyridine is a compound of interest for researchers in synthetic organic chemistry, who are exploring its potential uses and reactions in the synthesis of complex organic molecules.

InChI:InChI=1/C6H5NO2/c1-2-5-6(7-3-1)9-4-8-5/h1-3H,4H2

Upstream product

• 16867-04-2 dihydroxypyridine 
• 74-95-3 1,1-dibromomethane 

Relevant academic research and scientific papers

NOVEL ANTIVIRAL COMPOUNDS

The present invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing a viral infection such as HIV using the same.

QUINAZOLINE DERIVATIVES AS SRC TYROSINE KINASE INHIBITORS

The invention concerns quinazoline derivatives of Formula (I): (A chemical formula should be inserted here - please see paper copy enclosed herewith) wherein Z is an O, S, SO, SO2, N(R2) or C(R2)2 group wherein each R2 group is hydrogen or (1-8C) alkyl, m is 0, 1, 2 or 3, each R1 group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other meanings defined in the description, n is 0, 1, 2 or 3, and each R3 group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other meanings defined in the description, or pharmaceutically-acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.

3-CYANO-QUINOLINE DERIVATIVES AS NON-RECEPTOR TYROSINE KINASE INHIBITORS

The invention concerns quinoline derivatives of: (Formula I) (A chemical formula should be inserted here - please see paper copy enclosed herewith) wherein Z is an O, S, SO, SO2, N(R2) or C(R2)(R3) group wherein each R2 or R3 group is hydrogen or (1-6C)alkyl, m is 1, 2 or 3, each R1 group is selected from halogeno, (1-6C)alkyl, (1-6C)alkoxy and any of the other meanings defined in the description, Ra is hydrogen or halogeno, Rb is hydrogen, halogeno, (1-6C)alkyl or (1-6C)alkoxy, Rc is (1-6C)alkoxy and Rd is hydrogen, halogeno, (1-6C)alkyl or (1-6C)alkoxy, or Rc and Rd together form a (1-3C)alkylenedioxy group, or pharmaceutically acceptable salts thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.